Pulmonary Nodule Clinical Trial
Official title:
Application of Intelligent Augmented Reality Glasses in Assisting the Localization of Small Pulmonary Nodules:A Prospective, Randomized, Controlled, Noninferiority Trial
This study aims to conduct a large-sample randomized controlled clinical trial, using traditional CT-guided thoracic puncture localization as a comparison, to explore the accuracy, safety and clinical advantages of Intelligent AR glasses in assisting preoperative localizing of small pulmonary nodules.
Status | Recruiting |
Enrollment | 166 |
Est. completion date | December 1, 2024 |
Est. primary completion date | December 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Age 18-80, no gender limit; 2. Chest CT shows that the nodule involves the outer third of the lung and can be removed by wedge resection; 3. Chest CT (lung window mode), the maximum diameter of the nodule is =2 cm; 4. Physical condition score ECOG 0-2 points; 5. If you plan to undergo percutaneous puncture and localization of small pulmonary nodules, the puncture needle path will be determined by the attending physician; 6. Patients voluntarily participate and sign informed consent. Exclusion Criteria: 1. The lesion is located in front of the scapula, and the needle path is blocked; 2. The distance between the center of the lesion and the top of the diaphragm is < 3 cm; 3. The lesion is adjacent to the hilus or large blood vessels; 4. Pleural adhesions caused by a history of thoracotomy or pleural infection; 5. The patient voluntarily withdraws midway. |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Pulmonary Hospital | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Pulmonary Hospital, Shanghai, China |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy of puncture localization of pulmonary nodules | Quantified as the shortest distance from the actual position of the puncture needle tip to the originally planned puncture point | Intraoperative | |
Secondary | Success rate of puncture localization of pulmonary nodules | The puncture is defined as successful when the distance between the actual localizing point of the puncture needle tip and the center of the localized nodule does not exceed 20 mm. | Intraoperative | |
Secondary | Adjust the number of needle punctures | Number of needle insertion attempts required for successful localizing | Intraoperative | |
Secondary | Operating time | The time span from the patient's first CT scan to the last CT scan, in minutes | Intraoperative | |
Secondary | Radiation dose | The length product value of the radiation dose recorded by the CT scanner, measured in mGy * cm | Intraoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05160571 -
A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions
|
||
Not yet recruiting |
NCT04156360 -
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
|
||
Not yet recruiting |
NCT05848635 -
Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled
|
Phase 4 | |
Recruiting |
NCT06074133 -
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
|
||
Active, not recruiting |
NCT03893539 -
Clinical Utility for Ion Endoluminal System
|
N/A | |
Recruiting |
NCT04890301 -
Puncture Template Assisted Biopsy for Pulmonary Nodules
|
N/A | |
Completed |
NCT03731156 -
Granulomatous Pneumocystis Pneumonia
|
||
Completed |
NCT00917137 -
Transbronchial Needle Aspiration in the Diagnosis of Peripheral Pulmonary Malignancy
|
N/A | |
Completed |
NCT04805723 -
Effects of Surgery Types in Patients With Pulmonary Nodules
|
N/A | |
Recruiting |
NCT03824535 -
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
|
Phase 2 | |
Completed |
NCT04182815 -
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung
|
||
Completed |
NCT00906503 -
Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules
|
Phase 1 |